December 10th & 11th, 2026
15th edition
MARSEILLE, FR

Challenging conventional wisdom: Is early-stage capital as satisfyingly available in Europe as we like to believe?

Challenging conventional wisdom: Is early-stage capital as satisfyingly available in Europe as we like to believe?

How is it crucial to question the accepted common idea that Europe only lacks bigger funds for bigger roundtables and for more mature companies? Compared to European later-stage investment markets which are positively underfunded, it seems at first glance that the early-stage capital market is healthy and well-fuelled, but is it genuinely the case? Is the European early-stage capital market as rich in players and capital as it is said to be?

Frank Hensel

Principal
High-Tech Gründerfonds

Anta Gkelou

Analyst, Capital Funds
Sofinnova Partners

Cyril Teixeira Da Silva

Investment Officer
EUROPEAN INVESTMENT BANK

Rémi Droller

Managing Partner
Kurma Partners
Scroll to Top

Before you leave…

Download the official BioFIT 2026 brochure

Discover the conference programme, partnership opportunities, attendee profiles, registration options and everything you need to make the most of BioFIT 2026.